Evidence map›Paper›PMID 29468815›Full record

ReviewMolecular nutrition & food research2018

Isothiocyanates: Translating the Power of Plants to People.

Dushani L Palliyaguru, Jian-Min Yuan, Thomas W Kensler, Jed W Fahey

Abstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Phytochemicals Controlling EnterohemorrhagicInternational journal of molecular sciences · 2025
    Review
  17. Review
  18. The Anti-AGEing and RAGEing Potential of Isothiocyanates.Molecules (Basel, Switzerland) · 2024
    Review
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dushani L PalliyaguruDepartment of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jian-Min YuanDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Thomas W KenslerDepartment of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jed W FaheyDepartments of Medicine, Pharmacology and Molecular Sciences, International Health and Cullman Chemoprotection Center, Johns Hopkins University, Baltimore, MD, USA.
University of Pittsburgh · USJohns Hopkins University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Heath Devin Skinner · 2004 to 2026
$49.6M
Targeting Nrf2 for Cancer ChemopreventionR35CA197222 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KENSLER, THOMAS W · 2015 to 2021
$6.7M
Randomized Clinical Trial of Lung Cancer Chemoprevention with Sulforaphane in Former SmokersR01CA213123 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2017 to 2021
$3.2M
Detoxication of Air Pollutants in Humans with a Broccoli SupplementR01CA190610 · NCI · JOHNS HOPKINS UNIVERSITY · PI GROOPMAN, JOHN D · 2015 to 2019
$2.1M
The Singapore Chinese Health StudyU01CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2019 to 2019
$150k
Breast Cancer Research FoundationNCI NIH HHS P30 CA047904NCI NIH HHS P50 CA097190NCI NIH HHS R01 CA190610NCI NIH HHS R01 CA213123NCI NIH HHS R35 CA197222NCI NIH HHS U01 CA182876NIH HHS P30 CA047904)NIH HHS P50 CA097190NIH HHS R01 CA190610NIH HHS R01 CA213123NIH HHS R35 CA197222The Lewis B. and Dorothy Cullman Foundation
6 · The paper itself

Abstract

Isothiocyanates from cruciferous vegetables have been studied extensively in cells and in animals for their disease preventive and therapeutic effects. However, translating their utility to human populations has been both limited and challenging. Herein, clinical trials employing two isothiocyanates, sulforaphane (SFN; 1-isothiocyanato-4-(methylsulfinyl) butane) and phenethyl isothiocyanate (PEITC; 2-isothiocyanatoethylbenzene) that are isolated principally from broccoli and watercress, respectively, are summarized and discussed. Both of these compounds have been used in small human clinical trials, either within food matrices or as single agents, against a variety of diseases ranging from cancer to autism. Results suggest an opportunity to incorporate them, or more likely preparations derived from their source plants, into larger human disease mitigation efforts. The context for the applications of these compounds and plants in evidence-based food and nutritional policy is also evaluated.

Indexed as

BrassicaCardiovascular DiseasesClinical Trials as TopicDiabetes Mellitus, Type 2HumansIsothiocyanatesNeoplasmsSkin DiseasesSulfoxidesTreatment OutcomeVegetablesIsothiocyanatesphenethyl isothiocyanatesulforaphaneSulfoxidesbroccoliclinical trialsisothiocyanatephenethyl isothiocyanatesulforaphanewatercress

Identifiers

PMID29468815
PMCPMC6226005
OpenAlexW2793589433

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.